Table 2.
Participants characteristics of clinical validation cases
| Clinical validation cases: N = 132 | |
|---|---|
| Age | 75.0 ± 12.5 |
| Male | 72 (54.5%) |
| Hypertension | 107 (81.1%) |
| Diabetes mellitus | 33 (25.0%) |
| Dyslipidaemia | 61 (46.2%) |
| Atrial fibrillation at enrolment) | 41 (31.1%) |
| Heart rate (beats per minute) | 74.4 ± 17.3 |
| History of stroke/TIA | 16 (12.1%) |
| History of myocardial infarction | 19 (16.5%) |
| History of CABG | 11 (8.3%) |
| NYHA classification I/II/III/IV | 29/37/59/7 |
| LVEF (%) | 54.5 ± 13.1 |
| Aortic stenosis (no/I/II/III) | 34/28/28/42 (25.8%/21.2%/21.2%/31.8%) |
| Severe low-flow low-gradient AS | 8 |
| Aortic regurgitation (no/I/II/III) | 63/46/23/0 (47.7%/34.8%/17.4%/0%) |
| Mitral stenosis (no/I/II/III) | 117/13/2/0 (88.6%/9.8%/1.5%/0%) |
| Mitral regurgitation (no/I/II/III) | 31/56/27/18 (23.5%/42.4%/20.5%/13.6%) |
| Tricuspid stenosis (no/I/II/III) | 132/0/0/0 (100%/0%/0%/0%) |
| Tricuspid regurgitation (no/I/II/III) | 39/77/14/2 (29.5%/58.3%/10.6%/1.5%) |
| PQ interval (ms) | 180 ± 39 |
| QRS duration (ms) | 103 ± 26 |
| QT interval (ms) | 417 ± 46 |
| QRS axis (ms) | 16 ± 49 |
CABG, coronary artery bypass grafting; LVEF, left ventricular ejection fraction; TIA, transient ischaemic attack.